NCT04559243View on ClinicalTrials.gov

Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events

RecruitingOBSERVATIONAL
Enrollment

579

Participants

Timeline

Start Date

November 12, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2027

Conditions
Non-valvular Atrial FibrillationEmbolic Stroke
Interventions
DIAGNOSTIC_TEST

Transthoracic Echocardiography

After the surgey, the tests data will be collected during 8 visits when the subjects go back to the hospital.

Trial Locations (5)

200000

RECRUITING

Shanghai Songjiang District Central Hospital, Shanghai

250000

RECRUITING

Qilu Hospital of Shandong University, Jinan

325600

RECRUITING

The first Affiliated Hospital of WMU, Wenzhou

RECRUITING

The Second Affiliated Hospital and Yuying Children's Hospital of WMU, Wenzhou

621000

RECRUITING

Sichuan Mianyang 404 Hospital, Mianyang

All Listed Sponsors
lead

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY